Pilianidis, Georgios, et al. “Can Euglycemic Diabetic Ketoacidosis Caused by SGLT2 Inhibitors Be Avoided in COVID-19 and Other Acute Infections?”. European Journal of Case Reports in Internal Medicine, vol. 11, no. 3, Feb. 2024, https://doi.org/10.12890/2024_004282.